Migraine Disability Assessment (MIDAS)

ورودی‌های بالینی بیمار

حداقل ۰ — حداکثر ۹۰ • واحد: days

حداقل ۰ — حداکثر ۹۰ • واحد: days

حداقل ۰ — حداکثر ۹۰ • واحد: days

حداقل ۰ — حداکثر ۹۰ • واحد: days

حداقل ۰ — حداکثر ۹۰ • واحد: days

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
midas score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Grade I0–5
  • Grade II6–10
  • Grade III11–20
  • Grade IV21–999
Direct Clinical Answer

The Migraine Disability Assessment (MIDAS) calculates quantifying neurological deficit severity, stroke volume, and reperfusion therapy eligibility. Key inputs include missed work school. Scores guide initiating intravenous thrombolysis, activating endovascular thrombectomy pathways, or secondary prevention protocols. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Quantifies headache-related disability over a 3-month period to guide treatment decisions

Clinical Indication

The Migraine Disability Assessment (MIDAS) is indicated for bedside clinical practice to support Quantifies headache-related disability over a 3-month period to guide treatment decisions. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with acute neurological deficits, acute ischemic stroke, intracranial hemorrhage, seizures, or altered mental status. Clinical application is indicated across Comprehensive stroke centers, acute neurovascular units, neuro-ICU, and emergency neurology services.

Limitations & Contraindications

Stroke mimics including severe hypoglycemia, Todd postictal paresis, and hemiplegic migraine must be ruled out prior to intravenous thrombolysis.

Clinical Pearls & Action Plan

Time is brain; rapid determination of Last Known Well time and baseline functional status dictates reperfusion eligibility. Guideline pearl: Can be used to track treatment response over time.

Formula & Variables:

MIDAS Score = Q1 + Q2 + Q3 + Q4 + Q5

Input Parameters

NameTypeRequiredDescription
missed_work_schoolintegerYesDays in last 3 months missed work or school because of headaches(days)
reduced_work_schoolintegerYesDays in last 3 months productivity at work/school reduced by half or more(days)
missed_householdintegerYesDays in last 3 months did not do household work because of headaches(days)
reduced_householdintegerYesDays in last 3 months productivity in household work reduced by half or more(days)
missed_socialintegerYesDays in last 3 months missed family, social, or leisure activities(days)

Score Interpretation & Guidance

RangeStageDescription
0–5Grade ILittle or no disability
6–10Grade IIMild disability
11–20Grade IIIModerate disability
21–999Grade IVSevere disability

Evidence-Based References (EBM)

  • Stewart WF, Lipton RB, Kolodner K, Liberman J, Sawyer J. Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalalgia. 1999 Mar;19(2):107-14; discussion 74.
  • Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology. 2001;56(6 Suppl 1):S20-8.
  • Stewart WF, Lipton RB, Kolodner KB, Sawyer J, Lee C, Liberman JN. Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain. 2000 Oct;88(1):41-52.

Related calculators